275 related articles for article (PubMed ID: 27226569)
1. Macrophage Migration Inhibitory Factor-CXCR4 Receptor Interactions: EVIDENCE FOR PARTIAL ALLOSTERIC AGONISM IN COMPARISON WITH CXCL12 CHEMOKINE.
Rajasekaran D; Gröning S; Schmitz C; Zierow S; Drucker N; Bakou M; Kohl K; Mertens A; Lue H; Weber C; Xiao A; Luker G; Kapurniotu A; Lolis E; Bernhagen J
J Biol Chem; 2016 Jul; 291(30):15881-95. PubMed ID: 27226569
[TBL] [Abstract][Full Text] [Related]
2. Identification of an Arg-Leu-Arg tripeptide that contributes to the binding interface between the cytokine MIF and the chemokine receptor CXCR4.
Lacy M; Kontos C; Brandhofer M; Hille K; Gröning S; Sinitski D; Bourilhon P; Rosenberg E; Krammer C; Thavayogarajah T; Pantouris G; Bakou M; Weber C; Lolis E; Bernhagen J; Kapurniotu A
Sci Rep; 2018 Mar; 8(1):5171. PubMed ID: 29581527
[TBL] [Abstract][Full Text] [Related]
3. Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific targeting.
Kontos C; El Bounkari O; Krammer C; Sinitski D; Hille K; Zan C; Yan G; Wang S; Gao Y; Brandhofer M; Megens RTA; Hoffmann A; Pauli J; Asare Y; Gerra S; Bourilhon P; Leng L; Eckstein HH; Kempf WE; Pelisek J; Gokce O; Maegdefessel L; Bucala R; Dichgans M; Weber C; Kapurniotu A; Bernhagen J
Nat Commun; 2020 Nov; 11(1):5981. PubMed ID: 33239628
[TBL] [Abstract][Full Text] [Related]
4. MIF interacts with CXCR7 to promote receptor internalization, ERK1/2 and ZAP-70 signaling, and lymphocyte chemotaxis.
Alampour-Rajabi S; El Bounkari O; Rot A; Müller-Newen G; Bachelerie F; Gawaz M; Weber C; Schober A; Bernhagen J
FASEB J; 2015 Nov; 29(11):4497-511. PubMed ID: 26139098
[TBL] [Abstract][Full Text] [Related]
5. MIF promotes B cell chemotaxis through the receptors CXCR4 and CD74 and ZAP-70 signaling.
Klasen C; Ohl K; Sternkopf M; Shachar I; Schmitz C; Heussen N; Hobeika E; Levit-Zerdoun E; Tenbrock K; Reth M; Bernhagen J; El Bounkari O
J Immunol; 2014 Jun; 192(11):5273-84. PubMed ID: 24760155
[TBL] [Abstract][Full Text] [Related]
6. Cross-kingdom mimicry of the receptor signaling and leukocyte recruitment activity of a human cytokine by its plant orthologs.
Sinitski D; Gruner K; Brandhofer M; Kontos C; Winkler P; Reinstädler A; Bourilhon P; Xiao Z; Cool R; Kapurniotu A; Dekker FJ; Panstruga R; Bernhagen J
J Biol Chem; 2020 Jan; 295(3):850-867. PubMed ID: 31811089
[TBL] [Abstract][Full Text] [Related]
7. MIF-chemokine receptor interactions in atherogenesis are dependent on an N-loop-based 2-site binding mechanism.
Kraemer S; Lue H; Zernecke A; Kapurniotu A; Andreetto E; Frank R; Lennartz B; Weber C; Bernhagen J
FASEB J; 2011 Mar; 25(3):894-906. PubMed ID: 21106938
[TBL] [Abstract][Full Text] [Related]
8. Kinetic Analysis of the Early Signaling Steps of the Human Chemokine Receptor CXCR4.
Perpiñá-Viciano C; Işbilir A; Zarca A; Caspar B; Kilpatrick LE; Hill SJ; Smit MJ; Lohse MJ; Hoffmann C
Mol Pharmacol; 2020 Aug; 98(2):72-87. PubMed ID: 32474443
[TBL] [Abstract][Full Text] [Related]
9. Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study.
Giannice R; Erreni M; Allavena P; Buscaglia M; Tozzi R
Cytokine; 2013 Nov; 64(2):509-15. PubMed ID: 23985752
[TBL] [Abstract][Full Text] [Related]
10. Heterocomplexes between the atypical chemokine MIF and the CXC-motif chemokine CXCL4L1 regulate inflammation and thrombus formation.
Brandhofer M; Hoffmann A; Blanchet X; Siminkovitch E; Rohlfing AK; El Bounkari O; Nestele JA; Bild A; Kontos C; Hille K; Rohde V; Fröhlich A; Golemi J; Gokce O; Krammer C; Scheiermann P; Tsilimparis N; Sachs N; Kempf WE; Maegdefessel L; Otabil MK; Megens RTA; Ippel H; Koenen RR; Luo J; Engelmann B; Mayo KH; Gawaz M; Kapurniotu A; Weber C; von Hundelshausen P; Bernhagen J
Cell Mol Life Sci; 2022 Sep; 79(10):512. PubMed ID: 36094626
[TBL] [Abstract][Full Text] [Related]
11. Exploring the binding mechanisms of MIF to CXCR2 using theoretical approaches.
Xu L; Li Y; Li D; Xu P; Tian S; Sun H; Liu H; Hou T
Phys Chem Chem Phys; 2015 Feb; 17(5):3370-82. PubMed ID: 25526079
[TBL] [Abstract][Full Text] [Related]
12. Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74.
Lue H; Dewor M; Leng L; Bucala R; Bernhagen J
Cell Signal; 2011 Jan; 23(1):135-44. PubMed ID: 20807568
[TBL] [Abstract][Full Text] [Related]
13. Structural determinants of MIF functions in CXCR2-mediated inflammatory and atherogenic leukocyte recruitment.
Weber C; Kraemer S; Drechsler M; Lue H; Koenen RR; Kapurniotu A; Zernecke A; Bernhagen J
Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16278-83. PubMed ID: 18852457
[TBL] [Abstract][Full Text] [Related]
14. Studying the Pro-Migratory Effects of MIF.
Hoffmann A; Zwißler LC; El Bounkari O; Bernhagen J
Methods Mol Biol; 2020; 2080():1-18. PubMed ID: 31745866
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-induced endothelial secretion of macrophage migration inhibitory factor and role in endothelial progenitor cell recruitment.
Simons D; Grieb G; Hristov M; Pallua N; Weber C; Bernhagen J; Steffens G
J Cell Mol Med; 2011 Mar; 15(3):668-78. PubMed ID: 20178462
[TBL] [Abstract][Full Text] [Related]
16. Macrophage Migration Inhibitory Factor (MIF) Supports Homing of Osteoclast Precursors to Peripheral Osteolytic Lesions.
Movila A; Ishii T; Albassam A; Wisitrasameewong W; Howait M; Yamaguchi T; Ruiz-Torruella M; Bahammam L; Nishimura K; Van Dyke T; Kawai T
J Bone Miner Res; 2016 Sep; 31(9):1688-700. PubMed ID: 27082509
[TBL] [Abstract][Full Text] [Related]
17. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment.
Bernhagen J; Krohn R; Lue H; Gregory JL; Zernecke A; Koenen RR; Dewor M; Georgiev I; Schober A; Leng L; Kooistra T; Fingerle-Rowson G; Ghezzi P; Kleemann R; McColl SR; Bucala R; Hickey MJ; Weber C
Nat Med; 2007 May; 13(5):587-96. PubMed ID: 17435771
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for chemokine recognition by a G protein-coupled receptor and implications for receptor activation.
Ziarek JJ; Kleist AB; London N; Raveh B; Montpas N; Bonneterre J; St-Onge G; DiCosmo-Ponticello CJ; Koplinski CA; Roy I; Stephens B; Thelen S; Veldkamp CT; Coffman FD; Cohen MC; Dwinell MB; Thelen M; Peterson FC; Heveker N; Volkman BF
Sci Signal; 2017 Mar; 10(471):. PubMed ID: 28325822
[TBL] [Abstract][Full Text] [Related]
19. Macrophage Migration Inhibitory Factor (MIF)-Based Therapeutic Concepts in Atherosclerosis and Inflammation.
Sinitski D; Kontos C; Krammer C; Asare Y; Kapurniotu A; Bernhagen J
Thromb Haemost; 2019 Apr; 119(4):553-566. PubMed ID: 30716779
[TBL] [Abstract][Full Text] [Related]
20. MIF, CD74 and other partners in kidney disease: tales of a promiscuous couple.
Sanchez-Niño MD; Sanz AB; Ruiz-Andres O; Poveda J; Izquierdo MC; Selgas R; Egido J; Ortiz A
Cytokine Growth Factor Rev; 2013 Feb; 24(1):23-40. PubMed ID: 22959722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
